StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
April 24, 2017 9:35 AM
Canaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
April 24, 2017 9:14 AM
Quest Diagnostics (DGX) PT Raised to $100 at Barclays Following 1Q Report; Best Headline Growth in 2 Years
April 21, 2017 9:15 AM
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM
Raymond James Upgrades Quest Diagnostics (DGX) to Outperform
April 21, 2017 5:50 AM
Quest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI
April 20, 2017 1:03 PM
Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
April 20, 2017 6:47 AM
